Business Context and Reporting Period
This Form 6-K filing by Adherex Technologies Inc. (referred to as Fennec Pharmaceuticals Inc. in metadata) is dated May 9, 2006. The report discloses a material change involving the completion of a private placement offering and the filing of voting results from the Annual General Meeting of Shareholders.
Key Financial Metrics
The filing focuses on capital raising activities rather than operational financial performance.
- Gross Proceeds: Approximately $6.5 million USD.
- Units Issued: 7,752,853 units.
- Price Per Unit: $0.84 USD.
- Unit Composition: One common share and 0.30 of a common share purchase warrant.
- Warrant Terms: Exercisable for four years at $0.97 per share.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions outside of the proceeds from this specific transaction.
Material Changes
The primary material change reported is the successful completion of a private placement on May 8, 2006, following firm commitments announced on May 4, 2006. The offering targeted new institutional investors in the United States. Additionally, the company filed voting results for its Annual General Meeting.
Guidance, Outlook, and Risks
The filing does not contain specific forward-looking guidance, management commentary on future operations, or a detailed discussion of risks and contingencies beyond the standard disclosure regarding the private placement terms. The document notes that the information is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the final number of units issued (7,752,853) and the exact gross proceeds received ($6.5 million).
- Confirm the exercise price ($0.97) and expiration period (4 years) of the attached warrants.
- Review the attached press releases (Exhibits 99.1 and 99.2) for details on the specific institutional investors involved.
- Check the voting results (Exhibit 99.4) for any significant shareholder resolutions passed at the Annual General Meeting.